scispace - formally typeset
Open AccessJournal ArticleDOI

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.

TLDR
Emodin, an anthraquinone compound derived from genus Rheum and Polygonum, significantly blocked the S protein and ACE2 interaction in a dose-dependent manner and suggested that emodin may be considered as a potential lead therapeutic agent in the treatment of SARS.
About
This article is published in Antiviral Research.The article was published on 2007-05-01 and is currently open access. It has received 354 citations till now. The article focuses on the topics: Emodin & Rheum officinale.

read more

Citations
More filters
Journal ArticleDOI

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

TL;DR: This study presents an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the HCoV–host interactome and drug targets in the human protein–protein interaction network.
Journal ArticleDOI

Potential Interventions for Novel Coronavirus in China: A Systematic Review

TL;DR: It is suggested that all the potential interventions be implemented to control the emerging COVID‐19 if the infection is uncontrollable and the current children's RNA‐virus vaccines including influenza vaccine should be immunized for uninfected people and health care workers.
Journal ArticleDOI

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.

TL;DR: The interaction between the viral spike protein and angiotensin-converting enzyme 2, which triggers entry of the virus into host cells, is likely to be involved in the cardiovascular manifestations of COVID-19.
Journal ArticleDOI

COVID-19 diagnosis and management: a comprehensive review.

TL;DR: An overview of the known clinical features and treatment options for COVID‐19 is provided and quarantine is the only intervention that appears to be effective in decreasing the contagion rate.
Journal ArticleDOI

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.

TL;DR: Clinical evidence showing the beneficial effect of TCM in the treatment of patients with SARS coronaviral infections are discussed and experiment studies that provide an insight into the mechanism underlying the therapeutic effect ofTCM are introduced.
References
More filters
Journal ArticleDOI

Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide

TL;DR: Niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentration of 1.56 μM, as revealed by immunoblot analysis.
Journal ArticleDOI

Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin.

TL;DR: A molecular mechanism based on the effect of these compounds on the structure of biological membranes is proposed to account for their multiple biological activities.
PatentDOI

Inhibition of SARS coronavirus infection with clinically approved antiviral drugs

TL;DR: In this paper, the authors proposed methods for treating or inhibiting SARS-CoV infection involving the administration of an interferon, particularly IFN α-n1, IFN β-1b, and human leukocyte IFNα or IFNβα.
Journal ArticleDOI

Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein Core

TL;DR: The biophysical analysis of the two predicted heptad repeat regions within the severe acute respiratory syndrome coronavirus S protein shows that in isolation the HR-N region forms a stable α-helical coiled coil that associates in a tetrameric state, which is consistent with the structures observed for other type 1 viral fusion proteins in their fusion-competent state.
Journal ArticleDOI

S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients

TL;DR: Evidence that SARS-CoV infection might not be limited to lung tissue and can be inhibited by the humoral immune response in infected patients is provided, and results show that viral pseudotyping can be employed for the analysis of SARS -CoV S function.
Related Papers (5)